spendergast captains blog

Health Care Systems Oncology, Imaging and Pharmacology, particularly for Prostate Cancer. Technology that interests me: Sensors (Radar, Sonar, EO/IR,Fusion) Communications, Satellites, Unmanned Vehicles (UAV), Information Technology, Intelligent Transportation

Friday, July 31, 2020

Adding carboplatin to chemotherapy regimens for metastatic castrate‐resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment response and survival outcomes - Ahmed - - The Prostate - Wiley Online Library

Adding carboplatin to chemotherapy regimens for metastatic castrate‐resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment response and survival outcomes - Ahmed - - The Prostate - Wiley Online Library
Posted by Stephen Pendergast at 3:16 PM No comments:

Prostatepedia Digest 7.31.2020

Prostatepedia Digest 7.31.2020
Posted by Stephen Pendergast at 3:15 PM No comments:

AKR1C3 mediates pan‐AR antagonist resistance in castration‐resistant prostate cancer - Hertzog - - The Prostate - Wiley Online Library

AKR1C3 mediates pan‐AR antagonist resistance in castration‐resistant prostate cancer - Hertzog - - The Prostate - Wiley Online Library
Posted by Stephen Pendergast at 3:07 PM No comments:

Thursday, July 30, 2020

ADT for Prostate Cancer: Concern That Injections Often Given Late

ADT for Prostate Cancer: Concern That Injections Often Given Late
Posted by Stephen Pendergast at 3:26 PM No comments:

An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study - The Lancet Digital Health

An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study - The Lancet Digital Health
Posted by Stephen Pendergast at 9:08 AM No comments:

Tuesday, July 28, 2020

"Synthetic lethality" kills cancer by blocking DNA repair mechanism

"Synthetic lethality" kills cancer by blocking DNA repair mechanism
Posted by Stephen Pendergast at 5:54 PM No comments:

Tumour–capsule interface measured on 18F‐DCFPyL PSMA positron emission tomography/CT imaging comparable to multi‐parametric MRI in predicting extra‐prostatic extension of prostate cancer at initial staging - Brauchli - - Journal of Medical Imaging and Radiation Oncology - Wiley Online Library

Tumour–capsule interface measured on 18F‐DCFPyL PSMA positron emission tomography/CT imaging comparable to multi‐parametric MRI in predicting extra‐prostatic extension of prostate cancer at initial staging - Brauchli - - Journal of Medical Imaging and Radiation Oncology - Wiley Online Library
Posted by Stephen Pendergast at 5:53 PM No comments:

Monday, July 27, 2020

COVID-19 and prostate cancer management | THE "NEW" PROSTATE CANCER INFOLINK

COVID-19 and prostate cancer management | THE "NEW" PROSTATE CANCER INFOLINK
Posted by Stephen Pendergast at 5:03 PM No comments:

Friday, July 24, 2020

Crosstalk between COVID-19 and prostate cancer | Prostate Cancer and Prostatic Diseases

Crosstalk between COVID-19 and prostate cancer | Prostate Cancer and Prostatic Diseases
Posted by Stephen Pendergast at 9:09 AM No comments:

Thursday, July 23, 2020

An up-to-date catalogue of urinary markers for the managemen... : Current Opinion in Urology

An up-to-date catalogue of urinary markers for the managemen... : Current Opinion in Urology
Posted by Stephen Pendergast at 11:21 AM No comments:

Where to next prostate-specific membrane antigen PET imaging... : Current Opinion in Urology

Where to next prostate-specific membrane antigen PET imaging... : Current Opinion in Urology
Posted by Stephen Pendergast at 11:20 AM No comments:

Prostate cancer treatment and quality of life in the “real world” | THE "NEW" PROSTATE CANCER INFOLINK

Prostate cancer treatment and quality of life in the “real world” | THE "NEW" PROSTATE CANCER INFOLINK
Posted by Stephen Pendergast at 11:19 AM No comments:

Using AI to identify the aggressiveness of prostate cancer

Using AI to identify the aggressiveness of prostate cancer
Posted by Stephen Pendergast at 10:37 AM No comments:

Tuesday, July 21, 2020

Switching from Abiraterone Plus Prednisone to Abiraterone Plus Dexamethasone Can Extend Its Effectiveness — Cancer ABCs

Switching from Abiraterone Plus Prednisone to Abiraterone Plus Dexamethasone Can Extend Its Effectiveness — Cancer ABCs
Posted by Stephen Pendergast at 6:14 PM No comments:

Germlines 'Rich Source' of Prostate Cancer Info

Germlines 'Rich Source' of Prostate Cancer Info: New guidelines on germline testing are a rich source of information for clinicians. Lead author Dr Veda Giri discusses how they can best take advantage of them.
Posted by Stephen Pendergast at 2:45 PM No comments:

The Oncologist's Role With Savvy Patients

The Oncologist's Role With Savvy Patients
Posted by Stephen Pendergast at 2:44 PM No comments:

Monday, July 20, 2020

Identifying and treating ROBO1−ve/DOCK1+ve prostate cancer: An aggressive cancer subtype prevalent in African American patients - Ferrari - - The Prostate - Wiley Online Library

Identifying and treating ROBO1−ve/DOCK1+ve prostate cancer: An aggressive cancer subtype prevalent in African American patients - Ferrari - - The Prostate - Wiley Online Library
Posted by Stephen Pendergast at 11:20 AM No comments:

Sunday, July 19, 2020

Study: PSMA PET/CT is Effective in Detection and Management of Recurrent Prostate Cancer | Cooking with Kathy Man

Study: PSMA PET/CT is Effective in Detection and Management of Recurrent Prostate Cancer | Cooking with Kathy Man
Posted by Stephen Pendergast at 11:08 AM No comments:

Saturday, July 18, 2020

PI-RADS score v.2 in predicting malignancy in patients undergoing 5α-reductase inhibitor therapy | Prostate Cancer and Prostatic Diseases

PI-RADS score v.2 in predicting malignancy in patients undergoing 5α-reductase inhibitor therapy | Prostate Cancer and Prostatic Diseases
Posted by Stephen Pendergast at 6:56 PM No comments:

Wednesday, July 15, 2020

MRI Reliably Identifies Significant Prostate Cancer

MRI Reliably Identifies Significant Prostate Cancer
Posted by Stephen Pendergast at 10:34 AM No comments:

Monday, July 13, 2020

Temporal trends in the number of men electing for conservative management for low-risk prostate cancer in the United States | Prostate Cancer and Prostatic Diseases

Temporal trends in the number of men electing for conservative management for low-risk prostate cancer in the United States | Prostate Cancer and Prostatic Diseases
Posted by Stephen Pendergast at 4:03 PM No comments:

Prostate Cancer 2020: “The Times They Are a’Changing”: Cancer Cell

Prostate Cancer 2020: “The Times They Are a’Changing”: Cancer Cell
Posted by Stephen Pendergast at 4:02 PM No comments:

A new hormonal therapy for prostate cancer is under expedited FDA review - Harvard Health Blog - Harvard Health Publishing

A new hormonal therapy for prostate cancer is under expedited FDA review - Harvard Health Blog - Harvard Health Publishing
Posted by Stephen Pendergast at 4:01 PM No comments:

Physicians, Patients Need to Know Limits of DNA Privacy Law

Physicians, Patients Need to Know Limits of DNA Privacy Law
Posted by Stephen Pendergast at 4:00 PM No comments:

Saturday, July 11, 2020

Man plans to sue NHS after cancer surgery delayed due to coronavirus | Society | The Guardian

Man plans to sue NHS after cancer surgery delayed due to coronavirus | Society | The Guardian
Posted by Stephen Pendergast at 10:49 AM No comments:

Friday, July 10, 2020

Interim results of a prospective PSMA-directed focal stereotactic re-irradiation trial for locally recurrent prostate cancer - International Journal of Radiation Oncology, Biology, Physics

Interim results of a prospective PSMA-directed focal stereotactic re-irradiation trial for locally recurrent prostate cancer - International Journal of Radiation Oncology, Biology, Physics
Posted by Stephen Pendergast at 3:48 PM No comments:

Do you have ADVANCED prostate cancer? | THE "NEW" PROSTATE CANCER INFOLINK

Do you have ADVANCED prostate cancer? | THE "NEW" PROSTATE CANCER INFOLINK
Posted by Stephen Pendergast at 9:46 AM No comments:

The prognostic value of pain in castration-sensitive prostate cancer | Prostate Cancer and Prostatic Diseases

The prognostic value of pain in castration-sensitive prostate cancer | Prostate Cancer and Prostatic Diseases
Posted by Stephen Pendergast at 9:45 AM No comments:

Thursday, July 9, 2020

Study sheds light on how cancer spreads in blood: Analysis of particles shed by tumors points to new, less invasive way to diagnose malignancies -- ScienceDaily

Study sheds light on how cancer spreads in blood: Analysis of particles shed by tumors points to new, less invasive way to diagnose malignancies -- ScienceDaily
Posted by Stephen Pendergast at 5:49 PM No comments:

Risk of erectile dysfunction after modern radiotherapy for intact prostate cancer | Prostate Cancer and Prostatic Diseases

Risk of erectile dysfunction after modern radiotherapy for intact prostate cancer | Prostate Cancer and Prostatic Diseases
Posted by Stephen Pendergast at 9:27 AM No comments:

Wednesday, July 8, 2020

PTEN and ERG expression in MRI‐ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancer - Erickson - - The Prostate - Wiley Online Library

PTEN and ERG expression in MRI‐ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancer - Erickson - - The Prostate - Wiley Online Library
Posted by Stephen Pendergast at 8:52 AM No comments:

Monday, July 6, 2020

New Focus on ADT in Prostate Cancer Guideline | MedPage Today

New Focus on ADT in Prostate Cancer Guideline | MedPage Today
Posted by Stephen Pendergast at 3:03 PM No comments:

Enzalutamide Improves Survival in Men With Metastatic Prostate Cancer

Enzalutamide Improves Survival in Men With Metastatic Prostate Cancer
Posted by Stephen Pendergast at 9:28 AM No comments:
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Search This Blog

Blog Archive

  • ►  2025 (10)
    • ►  June (1)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (3)
    • ►  January (2)
  • ►  2024 (7)
    • ►  December (1)
    • ►  September (2)
    • ►  June (2)
    • ►  April (2)
  • ►  2023 (10)
    • ►  December (1)
    • ►  September (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (2)
    • ►  February (1)
  • ►  2021 (10)
    • ►  June (10)
  • ▼  2020 (370)
    • ►  October (53)
    • ►  September (94)
    • ►  August (43)
    • ▼  July (33)
      • Adding carboplatin to chemotherapy regimens for me...
      • Prostatepedia Digest 7.31.2020
      • AKR1C3 mediates pan‐AR antagonist resistance in ca...
      • ADT for Prostate Cancer: Concern That Injections O...
      • An artificial intelligence algorithm for prostate ...
      • "Synthetic lethality" kills cancer by blocking DNA...
      • Tumour–capsule interface measured on 18F‐DCFPyL PS...
      • COVID-19 and prostate cancer management | THE "NEW...
      • Crosstalk between COVID-19 and prostate cancer | P...
      • An up-to-date catalogue of urinary markers for the...
      • Where to next prostate-specific membrane antigen P...
      • Prostate cancer treatment and quality of life in t...
      • Using AI to identify the aggressiveness of prostat...
      • Switching from Abiraterone Plus Prednisone to Abir...
      • Germlines 'Rich Source' of Prostate Cancer Info
      • The Oncologist's Role With Savvy Patients
      • Identifying and treating ROBO1−ve/DOCK1+ve prostat...
      • Study: PSMA PET/CT is Effective in Detection and M...
      • PI-RADS score v.2 in predicting malignancy in pati...
      • MRI Reliably Identifies Significant Prostate Cancer
      • Temporal trends in the number of men electing for ...
      • Prostate Cancer 2020: “The Times They Are a’Changi...
      • A new hormonal therapy for prostate cancer is unde...
      • Physicians, Patients Need to Know Limits of DNA Pr...
      • Man plans to sue NHS after cancer surgery delayed ...
      • Interim results of a prospective PSMA-directed foc...
      • Do you have ADVANCED prostate cancer? | THE "NEW" ...
      • The prognostic value of pain in castration-sensiti...
      • Study sheds light on how cancer spreads in blood: ...
      • Risk of erectile dysfunction after modern radiothe...
      • PTEN and ERG expression in MRI‐ultrasound guided f...
      • New Focus on ADT in Prostate Cancer Guideline | Me...
      • Enzalutamide Improves Survival in Men With Metasta...
    • ►  June (40)
    • ►  May (51)
    • ►  April (45)
    • ►  March (11)
  • ►  2019 (4)
    • ►  September (1)
    • ►  March (1)
    • ►  February (1)
    • ►  January (1)
  • ►  2018 (7)
    • ►  November (1)
    • ►  October (1)
    • ►  September (2)
    • ►  April (1)
    • ►  February (1)
    • ►  January (1)
  • ►  2017 (55)
    • ►  November (1)
    • ►  October (7)
    • ►  September (7)
    • ►  August (6)
    • ►  July (4)
    • ►  June (3)
    • ►  May (5)
    • ►  April (5)
    • ►  March (7)
    • ►  February (4)
    • ►  January (6)
  • ►  2016 (126)
    • ►  December (4)
    • ►  November (5)
    • ►  October (10)
    • ►  September (12)
    • ►  August (15)
    • ►  July (9)
    • ►  June (14)
    • ►  May (12)
    • ►  April (3)
    • ►  March (15)
    • ►  February (11)
    • ►  January (16)
  • ►  2015 (448)
    • ►  December (23)
    • ►  November (23)
    • ►  October (27)
    • ►  September (35)
    • ►  August (35)
    • ►  July (21)
    • ►  June (35)
    • ►  May (49)
    • ►  April (52)
    • ►  March (34)
    • ►  February (48)
    • ►  January (66)
  • ►  2014 (542)
    • ►  December (88)
    • ►  November (66)
    • ►  October (81)
    • ►  September (73)
    • ►  August (39)
    • ►  July (26)
    • ►  June (35)
    • ►  May (38)
    • ►  April (11)
    • ►  March (16)
    • ►  February (26)
    • ►  January (43)
  • ►  2013 (261)
    • ►  December (71)
    • ►  November (55)
    • ►  October (80)
    • ►  September (48)
    • ►  July (4)
    • ►  June (1)
    • ►  April (1)
    • ►  March (1)
  • ►  2012 (46)
    • ►  December (6)
    • ►  November (1)
    • ►  October (1)
    • ►  September (3)
    • ►  August (7)
    • ►  July (1)
    • ►  June (1)
    • ►  May (2)
    • ►  April (2)
    • ►  March (5)
    • ►  February (7)
    • ►  January (10)
  • ►  2011 (57)
    • ►  December (4)
    • ►  November (3)
    • ►  October (10)
    • ►  September (3)
    • ►  August (9)
    • ►  July (12)
    • ►  June (6)
    • ►  May (1)
    • ►  March (4)
    • ►  February (4)
    • ►  January (1)
  • ►  2010 (74)
    • ►  December (5)
    • ►  November (6)
    • ►  October (4)
    • ►  September (7)
    • ►  August (10)
    • ►  July (6)
    • ►  June (14)
    • ►  May (4)
    • ►  April (10)
    • ►  March (3)
    • ►  February (2)
    • ►  January (3)
  • ►  2009 (40)
    • ►  August (2)
    • ►  July (5)
    • ►  June (10)
    • ►  May (13)
    • ►  April (5)
    • ►  January (5)
  • ►  2007 (43)
    • ►  June (6)
    • ►  March (15)
    • ►  February (22)

About Me

My photo
Stephen Pendergast
View my complete profile

Subscribe To

Posts
Atom
Posts
All Comments
Atom
All Comments

links

  • linkedin
Picture Window theme. Powered by Blogger.